Comparative effectiveness of etanercept and adalimumab in patient reported outcomes and injection-related tolerability Academic Article uri icon

Overview

MeSH Major

  • Adalimumab
  • Antirheumatic Agents
  • Etanercept

abstract

  • Convenience and fear of self-injection were important considerations to patients selecting a biologic drug. Although more convenient, adalimumab associated with more ISBS than did etanercept, and this rate was higher than reported in clinical trials. At 6 months, PROs did not differ between etanercept and adalimumab users.

publication date

  • March 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4805235

Digital Object Identifier (DOI)

  • 10.1371/journal.pone.0149781

PubMed ID

  • 27007811

Additional Document Info

start page

  • e0149781

volume

  • 11

number

  • 3